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Background. Male-factor infertility is a common condition, and etiology is unknown for a high proportion of cases. Abnormal
epigenetic programming of the germline is proposed as a possible mechanism compromising spermatogenesis of some men
currently diagnosed with idiopathic infertility. During germ cell maturation and gametogenesis, cells of the germ line undergo
extensive epigenetic reprogramming. This process involves widespread erasure of somatic-like patterns of DNA methylation
followed by establishment of sex-specific patterns by de novo DNA methylation. Incomplete reprogramming of the male germ
line could, in theory, result in both altered sperm DNA methylation and compromised spermatogenesis. Methodology/
Principal Finding. We determined concentration, motility and morphology of sperm in semen samples collected by male
members of couples attending an infertility clinic. Using MethyLight and Illumina assays we measured methylation of DNA
isolated from purified sperm from the same samples. Methylation at numerous sequences was elevated in DNA from poor
quality sperm. Conclusions. This is the first report of a broad epigenetic defect associated with abnormal semen parameters.
Our results suggest that the underlying mechanism for these epigenetic changes may be improper erasure of DNA methylation
during epigenetic reprogramming of the male germ line.
Citation: Houshdaran S, Cortessis VK, Siegmund K, Yang A, Laird PW, et al (2007) Widespread Epigenetic Abnormalities Suggest a Broad DNA
Methylation Erasure Defect in Abnormal Human Sperm. PLoS ONE 2(12): e1289. doi:10.1371/journal.pone.0001289
INTRODUCTION
Approximately five million women in the United States reported
difficulty in achieving a pregnancy in comprehensive surveys
conducted by the CDC and National Survey of Family Growth
from 1982 until 1995 [1–3], indicating that ten to twenty percent
of couples attempting pregnancy are infertile. Preliminary follow-
up data for 1990–2002 confirm this percentage [4–6]. Male factor
infertility accounts for 40–50% of this impaired fecundity [7]. Well
defined causes of male-factor infertility include congenital and
acquired dysfunction of the hypothalamic-pituitary-testicular
endocrine axis, anatomic defects, chromosomal abnormalities,
and point mutations [8–10]. However, these diagnoses account for
only a small proportion of cases, and etiology remains unknown
for most male-factor infertility patients [7,11].
Abnormal epigenetic programming of the germ line is
proposed as a possible mechanism compromising fertility of
some men currently diagnosed with idiopathic infertility. The
mammalian germ line undergoes extensive epigenetic repro-
gramming during development and gametogenesis. In males,
dramatic chromatin remodeling occurs during spermatogenesis
[12,13], and widespread erasure of DNA methylation followed
by de novo DNA methylation occurs developmentally in two
broad waves [12,14–17]. The first occurs before emergence of
the germ line, establishing a pattern of somatic-like DNA
hypermethylation in cells of the pre-implantation embryo that
are destined to give rise to all cells of the body, including germ
cells. The second widespread occurrence of erasure takes place
uniquely in primordial germ cells. Subsequent de novo methylation
occurs during germ cell maturation and spermatogenesis,
establishing a male germ line pattern of DNA methylation that
remains hypomethylated compared with somatic cell DNA
[14,18–22]. Disruption of one or more of these epigenetic
processes may lead to abnormal spermatogenesis and compro-
mised sperm function.
A small number of studies have addressed the epigenetic state of
the human male germ line. Substantial variation in DNA
methylation profiles is reported in ejaculated sperm of young,
apparently healthy men. Notable distinctions were observed both
between samples from separate men and among individually
assayed sperm from the same man [23]. Although this variation
suggests that DNA methylation may be used as a biomarker of
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study [23].
Several previous studies did assess sperm DNA methylation
together with either sperm quality or fertility outcomes. However,
measures of DNA methylation were limited, consisting of either
immunostain–a single and somewhat nonspecific measure [24]–or
sequence specific measures made at only one or two imprinted
genes–a rare and specialized subset of DNA methylation targets
[25–27].
To assess sperm DNA methylation at a more representative set
of targets, we selected a much larger set of sequence-specific assays
for use in the present study. We measured DNA methylation in
ejaculated spermatozoa, interrogating sequences in repetitive
elements, promoter CpG islands, and differentially methylated
regions (DMRs) of imprinted genes. Then, to address the possible
role of epigenetic programming in abnormal human spermato-
genesis, we related sequence-specific levels of DNA methylation to
standard measures of sperm quality. This is the first study to
describe the epigenetic state of abnormal human sperm using an
extensive panel of DNA methylation assays.
RESULTS
Standard semen analysis was conducted on samples collected by
69 men during clinical evaluation of couples with infertility.
Among the 69 samples, semen volume ranged from 0.5 to 7.8 ml;
total count 0 to 864 million sperm; total motile count 0 to 396
million sperm; and percentage normal sperm forms 0 to 26. Four
samples were found to be azoospermic and excluded from
subsequent analysis of DNA methylation.
We evaluated 294 MethyLight reactions (Table S1A–B) for the
presence of methylation in sperm DNA from an anonymous
semen sample obtained from a sperm bank. The 35 selected
reactions (Table S1A) were used to assay sperm DNA from 65
study samples. At many of the 35 sequences methylation levels
were elevated in DNA from poor quality sperm. Striking
associations with each of sperm concentration, motility and
morphology were observed for four sequences: NTF3, MT1A,
PAX8 and PLAGL1 (Figure 1).
PLAGL1 is maternally imprinted. Our MethyLight assay for this
gene interrogates a differentially methylated CpG island [28]. To
determine whether other maternally imprinted genes are methyl-
ated in abnormal sperm, we used MethyLight to interrogate the
differentially methylated sequence of DIRAS3. At this sequence we
also observed greater DNA methylation in samples with poorer
semen parameters (Figure 1). These results appeared to conflict
with those of Marques et al [26] who reported no association
between low sperm count and methylation of a DMR in a third
maternally imprinted gene, MEST. We therefore used MethyLight
to assess the methylation status of a differentially methylated
MEST sequence investigated by these authors [26], and found
elevated DNA methylation to be significantly associated with poor
semen parameters (Figure 1), in agreement with our PLAGL1 and
DIRAS3 results.
After correction for multiple comparisons, estimated associa-
tions between results of each of the 37 MethyLight assays and
sperm concentration were significant for HRAS, NTF3, MT1A,
PAX8, DIRAS3, PLAGL1, SFN, SAT2CHRM1 and MEST (Table 1,
Figure 1).
We then subjected MethyLight data from 36 of the assays to
unsupervised cluster analysis. (Data for SASH1 were not included,
because methylation at this sequence was detected in only one
sample.) This analysis identified three distinct clusters of sequences
based on DNA methylation profiles in the 65 samples (Figure 2).
Notably, the middle cluster shown in Figure 2 includes eight of the
nine sequences (all except MT1A) individually associated with
semen parameters. This middle cluster includes not only three
sequences that are differentially methylated on imprinted loci, but
also four single copy sequences specific to non-imprinted genes,
and a repetitive element, Satellite 2 [29] (reaction named
SAT2CHRM1). This result indicates that sperm abnormalities
may be associated with a broad epigenetic defect of elevated DNA
methylation at numerous sequences of diverse types, rather than a
defect of imprinting alone as previously suggested [26].
To learn more about the possible extent of this apparent defect,
we used the IlluminaH platform to conduct DNA methylation
analysis of 1,421 sequences in autosomal loci. We included in this
analysis DNA from the anonymous sperm sample used in the
MethyLight screen (Figure 3, column S), two purchased samples of
buffy coat DNA allowing us to observe methylation patterns in
somatic cells (Figure 3, columns 1–2), and seven study sperm DNA
samples remaining after MethyLight analysis (Figures 2–3,
columns A–G).
Results of Illumina analyses appear in Figure 3. A large number
of genes were similarly methylated in both sperm DNA and buffy
coat DNA (blue regions on the left bar, I; red regions on the right
bar, III), while others tended to be more methylated in DNA
isolated from only one of these cell types. Boxes enclose sequences
for which we observed particularly strong patterns of cell type-
specific methylation. Box 1 identifies 19 sequences with sperm-
specific DNA methylation. At these sequences, methylation
profiles of all DNA sperm samples (A–G, S) closely resemble one
another and differ greatly from those of buffy coat DNA. Box 2
identifies 102 sequences with buffy coat-specific DNA methylation.
This set is larger in number than the sperm-specific set, as
expected, given that sperm DNA is reportedly hypomethylated
compared with somatic cell DNA [20]. The buffy coat-specific set
comprises 7.2% of the 1,421 sequences including the majority of
DMRs associated with imprinted genes that are on the Illumina
panel. At many buffy coat-specific sequences, DNA methylation
notably was elevated in sample A that had been isolated from
sperm with the lowest concentration among samples A–G.
Methylation of sample A DNA is elevated (b.0.1) at 76 of the
102 sequences in box 2, including all 10 that are known DMRs
associated with imprinted genes.
Several factors assure us that our observations did not arise from
somatic cell contamination of separated sperm samples [27].
Somatic cells are far larger than sperm and readily identified by
microscopic evaluation of semen samples. Even if somatic cells are
present in the neat ejaculate, the IsolateH sperm separation
technique is specifically designed to separate spermatozoa from
somatic cells and miscellaneous debris [30]. Moreover, although
microscopic evaluation of semen samples conducted before sperm
separation identified white blood cells in five of the 65 neat semen
samples, we found that excluding results on these five samples
from statistical analyses had minimal effect on associations
between DNA methylation and semen parameters (results not
shown), and DNA from these samples were excluded from
Illumina assays.
DISCUSSION
Our observations are consistent with a broad epigenetic
abnormality of poor quality human sperm in which levels of
DNA methylation are elevated at numerous sequences in several
genomic contexts. Previous studies of DNA methylation in poor
quality human sperm interrogated only imprinted loci, measuring
methylation of sequences in only one or two genes [25–27].
In the only study addressing the relationship between DNA
methylation and fertility outcomes, immunostaining was used to
Sperm DNA Methylation Defect
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ejaculated sperm collected for conventional in vitro fertilization
(IVF). No association was observed between sperm DNA
methylation and either fertilization rate or embryo quality in 63
IVF cycles [24]. There was, however, a possible association with
pregnancy rate after transfer of good quality embryos. Interpre-
tation of these results is limited by both small sample size and the
use of a single summary measure of genome-wide DNA
methylation.
Because of the enormous number of methylation targets in the
human genome, only sequence-specific measures of DNA
methylation are expected to reveal variation at individual sites.
These include millions of repetitive DNA elements for which
methylation is postulated to silence parasitic and transposable
activity. There are also large numbers of target sequences
corresponding to single copy genes. Examples include thousands
of promoter CpG islands for which methylation appears to
mediate expression of genes in a tissue- and lineage-specific
fashion, and DMRs associated with dozens of imprinted genes for
which parent-of-origin DNA methylation marks are believed to
mediate monoallelic expression in somatic cells.
Sequence-specific measures were used in three previous studies
investigating the relationship between methylation of human
sperm DNA and spermatogenesis [25–27]. One study assessed
DNA from spermatogonia and spermatocytes microdissected from
seminiferous tubules of biopsied testicular tissue with spermato-
genic arrest. DNA profiles consistent with correctly established
paternal imprints were reported in all samples [25].
In the remaining two studies, DNA profiles were measured at
specific DMRs associated with each of two genes, one paternally
and one maternally imprinted. The resulting profiles were related
to concentration of ejaculated sperm, an indicator of sperm
quality. One of these studies reported correctly erased maternal
imprints and correctly established paternal imprints in DNA from
Figure 1. Box plots illustrating associations between semen parameters and level of methylation (PMR, on the natural-log scale) in DNA isolated
from 65 study sperm samples. DNA methylation was measured by MethyLight. Methylation targets were sequences specific to the genes HRAS,
NTF3, MT1A, PAX8, PLAGL1, DIRAS3, MEST and SFN and the repetitive element Satellite 2 (SAT2CHRM1). P-value for trend over category of semen
parameter is given for each plot. Rows: DNA methylation targets; columns: semen parameters.
doi:10.1371/journal.pone.0001289.g001
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that although maternal imprinting of MEST was correctly erased
in DNA from sperm of low concentration, methylation at an H19
sequence typically de novo methylated in spermatogenesis was
incomplete in these samples [26]. No compelling explanation was
offered for the apparently differing results of these studies. It is
noteworthy, however, that each addressed sequences of only one
or two imprinted genes, an extremely small and specialized subset
of DNA methylation targets in the human genome. Data from
these published studies could not, therefore, have revealed a
disruption involving large numbers of genes, or shown that genes
that are not imprinted are also affected. Our high-throughput
analysis addressing hundreds of DNA methylation targets was far
more likely to reveal such a defect.
Elevated DNA methylation could, in theory, arise from either
de novo methylation or improper erasure of pre-existing methyl-
ation. Although we cannot rule out the possibility that processes
responsible for de novo methylation are inappropriately activated
in abnormal spermatogenesis, disruption of erasure seems a
simpler mechanism. In mice, widespread erasure of DNA
methylation has been shown to occur in both the pre-
implantation embryo and again, uniquely, in primordial germ
cells around the time that they enter the genital ridge. Several
factors point to disruption of erasure in primordial germ cells as
underlying the defect that we postulate. Primordial germ cells
arise from cells of the proximal epiblast which have themselves
embarked upon somatic development, as shown by expression of
somatic genes [31,32]. The germ cell lineage must therefore
suppress the somatic program, which in mice is accomplished in
part by genome-wide erasure of DNA methylation soon after
germ cells migrate to the genital ridge [14,33–41]. Incomplete
erasure of DNA methylation at this stage of germ cell
development has been postulated to explain transmission of
variable phenotypes in several well characterized mouse models
[42–44]. This erasure affects DNA methylation on single copy
genes, imprinted genes and at least some repetitive elements
[33,34]. Therefore, its disruption could in theory result in the
type of pattern we observe in poor quality sperm, with elevated
levels of DNA methylation at DNA sequences of each of these
types. Further, because this erasure is confined to primordial
germ cells, we anticipate that its disruption would be compatible
with normal somatic development.
In humans, primordial germ cells colonize the genital ridge at
about 4.5 weeks of gestation. We are not aware of data
describing DNA methylation in the human germ line at this
date; however, the DMR in MEST at which we found elevated
DNA methylation in poor quality sperm is reportedly unmethy-
lated in the male germ line by week 24 of gestation [45]. We
have not investigated potential causes of disrupted erasure.
However, weeks 4.5–24 of gestation represent post-implantation
stages of development wherein fetal physiology may be
influenced by maternal factors and environmental compounds
that cross the placenta. Possible origins of male infertility as early
as 4.5 weeks of human gestation have not been studied.
However, transient in vivo chemical exposure at 7–15 days post
conception, which includes the analogous stage of murine
development [34,39], results in spermatogenic deficits in rats
with grossly normal testes [46] and may be associated with
elevated methylation of sperm DNA [47].
Taken together, the observations we report here suggest that
epigenetic mechanisms may contribute to some cases of male
factor infertility and that additional investigation of epigenetic
mechanisms is warranted. Research relating sperm DNA meth-
ylation profiles to fertility outcomes is underway in our laboratory,
and studies addressing pathophysiology associated with aberrant
sperm DNA methylation may provide long-awaited mechanistic
insights into abnormal sperm function. If, as we now postulate,
improper erasure of DNA methylation in primordial germ cells
results in an epigenetic defect of sperm, some categories of male
Table 1. Trend p-values for associations between MethyLight
results and semen parameters (see Methods).
......................................................................
MethyLight Reaction Parameter of Standard Semen Analysis
Concentration Motility Morphology
*HRAS.HB.144 0.00006 0.00001 0.06265
*NTF3.HB.251 0.00029 0.00026 0.00464
MT1A.HB.205 0.00048 0.00026 0.00119
*PAX.8.HB.212 0.00086 0.00405 0.05143
*DIRAS3.HB.043 0.00109 0.00159 0.06016
*PLAGL1.HB.199 0.00213 0.00255 0.01951
*SFN.HB.174 0.00307 0.00804 0.79899
*SAT2CHRM1.HB.289 0.00448 0.00109 0.06793
*MEST.HB.493 0.00711 0.00373 0.00359
RNR1.HB.071 0.02 0.04 0.89
CYP27B1.HB.223 0.02 0.05 0.10
MADH3.HB.053 0.09 0.15 0.35
BDNF.HB.257 0.11 0.05 0.26
PSEN1.HB.263 0.16 0.27 0.81
CGA.HB.237 0.23 0.34 0.93
SERPINB5.HB.208 0.23 0.64 0.80
ICAM1.HB.076 0.24 0.29 0.05
MINT1.HB.161 0.24 0.60 0.34
PTPN6.HB.273 0.24 0.09 0.08
ALU.HB.296 0.25 0.29 0.87
CYP1B1.HB.239 0.28 0.42 0.61
SP23.HB.301 0.28 0.48 0.48
IFNG.HB.311 0.33 0.22 0.93
C9.HB.403 0.37 0.35 0.89
GP2.HB.400 0.41 0.39 0.94
GATA4.HB.325 0.45 0.20 0.12
UIR.HB.189 0.48 0.47 0.70
TFF1.HB.244 0.48 0.96 0.93
LDLR.HB.219 0.51 0.39 0.11
SASH1.HB.085 0.51 0.15 0.15
ABCB1.HB.051 0.54 0.27 0.16
HOXA10.HB.270 0.63 0.84 0.13
MTHFR.HB.058 0.70 0.38 0.43
LINE1.HB.330 0.87 0.47 0.14
LZTS1.HB.200 0.90 0.95 0.73
SMUG1.HB.086 0.90 0.36 0.76
{IGF2.HB.345 0.91 0.71 0.11
*Belongs to cluster 2 (see Figure 2).
{Assay interrogates a non-differentially methylated sequence.
Trends were assessed over the following categories of semen parameters
[N=number samples in category]: Concentration (,5 [N=12], 5–20 [N=10],
.20 [N=43]610
6 sperm per ml), Total motile sperm count (,10 [N=18], 10–50
[N=14], .50 [N=33]610
6 sperm), Morphology (,5% [N=15], 5–14% [N=35],
.14% [N=13] normal sperm).
doi:10.1371/journal.pone.0001289.t001
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PLoS ONE | www.plosone.org 4 December 2007 | Issue 12 | e1289Figure 2. Cluster analysis of 36 MethyLight targets in 65 study sperm DNA samples. Left: dendrogram defining clusters; rows: 35 methylation
targets; columns: 65 study samples ordered left to right on sperm concentration (samples A–G were also included in Illumina analyses (see Figure 3))
with poor to good concentration (blue), motility (purple), and morphology (green) represented by darkest to lightest hue; body of figure:
standardized PMR values represented lowest to highest as yellow to red. X=missing.
doi:10.1371/journal.pone.0001289.g002
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PLoS ONE | www.plosone.org 5 December 2007 | Issue 12 | e1289factor infertility may be added to the growing list of diseases of
adulthood that have fetal origins, and etiologic studies addressing
events at this early stage of development will be needed.
MATERIALS AND METHODS
Semen samples
Study semen samples were collected by 69 consecutive men ages
22–49 years who were partners of women undergoing evaluation
for infertility at the Endocrine/Infertility Clinic of the Los Angeles
County/University of Southern California Keck School of
Medicine Medical Center. One additional semen sample was
obtained from a sperm bank. The study was approved by the
Institutional Review Board of the University of Southern
California. Informed consent was not required because this
research involved stored materials that had previously been
collected solely for non-research purposes and were anonymous
to the researchers/authors.
Figure 3. Results of Illumina analysis of 1,421 autosomal sequences in DNA isolated from sperm and buffy coat. Seven study sperm samples (A–G;
with values of sperm concentration (10
6 sperm/ml) A:20, B:56, C:62, D:67, E:75, F:94, G:95), screening sperm sample (S), two buffy coat samples (1–2).
Level of DNA methylation scored as b-value. Color: b-value for column sample at row sequence (green: b,0.1; yellow: 0.1#b#0.25; orange
0.25,b#0.5; red: b.0.5). MI and PI: maternally and paternally imprinted genes (black bar). Sequences assigned to tertile of median b-value among
buffy coat DNA samples (I, II, III) and sorted within tertile on median b-value among sperm DNA samples. Box 1: sequences with sperm-specific DNA
methylation; Box 2: sequences with buffy coat-specific DNA methylation.
doi:10.1371/journal.pone.0001289.g003
Sperm DNA Methylation Defect
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Standard semen analysis was performed using WHO criteria and
Strict Morphology as previously described [48,49]. Semen volume,
sperm concentration and motility, and leukocyte count were
measured using the MicroCell chamber (Conception Technolo-
gies, San Diego, CA). Sperm morphology was assessed with the
use of prestained slides (TestSimplets, Spectrum Technologies,
Healdsburgh, CA), and percentage of morphologically normal
sperm was documented. The samples were categorized according
to concentration (,5, 5–20, .20 million sperm/ml), motility
(,10, 10–50, .50 total motile sperm count (610
6)), and
morphology (,5%, 5–14%, .14% normal) of sperm [48,50].
Presence of any white blood cells, round cells, or epithelial cells
was recorded. Following semen analysis, samples were stored at
230uC until processing for molecular analysis.
Sperm Separation from Seminal Plasma
Semen samples were allowed to thaw at 37uC. Sperm were
separated from seminal plasma using IsolateH Sperm Separation
Medium (Irvine Scientific, Santa Ana, CA), a density gradient
centrifugation column designed to separate cellular contaminants
(including leukocytes, round cells, and miscellaneous debris) from
spermatozoa [30]. Separation was performed according to the
manufacturer’s protocol [51], and the purity of separated sperm
from contaminating cells was documented by light microscopy.
DNA isolation
DNA was isolated from purified sperm as previously described
[52], with 0.1X SSC added to the Lysis buffer, and samples
incubated at 55uC over night or longer to complete the lysis
procedure.
Laboratory Analysis of DNA Methylation
Sodium bisulfite conversion was performed as previously described
[29]. The amount of DNA in each aliquot was normalized, and a
bisulfite-dependent, DNA methylation-independent control reac-
tion was performed to confirm relative amounts of DNA in each
sample.
MethyLight analyses were performed as previously described
[29]. Reaction IDs and sequences of the primers and probes used
in the 294 MethyLight reactions are provided in Table S1 (sections
A–B). Thirty-five MethyLight reactions were selected for analysis
of study sperm DNA samples based on cycle threshold (C(t)) values
from analysis of the anonymous sample of sperm DNA. In brief,
C(t) value is the PCR cycle number at which the emitted
fluorescence is detectable above background levels. The C(t) value
is inversely proportional to the amount of each methylated locus in
the PCR reaction well, such that a low C(t) value suggests that the
interrogated sequence is highly methylated. We interpreted C(t)
values of 35 or less as an indication that a given sequence was
methylated in the anonymous sample and selected 33 reactions on
this basis. We included three additional reactions for which C(t)
values slightly exceeded 35. Two (CYP27B1 and HOXA10) were
selected based on gene function potentially related to fertility, and
one (a non-CpG island reaction for IFNG) based on prior
observation of hypomethylation in tumor versus normal tissue
(data not shown). When multiple reactions for a single locus
resulted in C(t) values of less than 35, we selected only the reaction
with the lowest C(t) value. Results of MethyLight analysis were
scored as PMR values as previously defined [29].
Following MethyLight analyses, DNA remained from a subset
of abnormal samples with greater sperm concentration. Illumina
analysis was performed on sodium bisulfite converted sperm DNA
of selected remaining samples, the anonymous semen sample, and
purchased buffy coat DNA (HemaCareH Corporation, Van Nuys,
CA) at the USC Genomics Core. Sodium bisulfite conversion for
Illumina assay was performed using the EZ-96 DNA Methylation
Kit (ZYMO Research) according to manufacturer’s protocol.
Illumina Methods and reagents are as previously described [53].
The primer names are listed in Table S2, identifying the 1,421
autosomal sequences on the GoldenGate Methylation Cancer Panel I,
more fully described elsewhere [54,55]. Results of Illumina assays
were scored as b-values [53].
Statistical association analyses of MethyLight data
Associations between the ranked MethyLight data and categorized
semen values (Table 1) were tested using simple linear regression,
with the semen characteristic categories scored as 0: low, 1: mid, 2:
high. For selected sequences, boxplots of the methylation values
(on the log(PMR+1) scale) are shown in Figure 1. The top and
bottom of the box denote the 75
th and 25
th percentiles, and the
white bar the median. Whiskers are drawn to the observation
farthest from the box that lies within 1.5 times the distance from
the top to the bottom of the box, with values falling outside the
whiskers denoted as lines. Results of this analysis were included in
Figure 1 for sequences associated with sperm concentration using
the Benjamini and Hochberg procedure [56] to control the false
discovery rate at 5%.
Statistical cluster analysis of MethyLight data
Hierarchical cluster analysis of 36 loci was performed, using
correlation to measure the distance between any two loci and
Ward’s method of linkage [57]. SASH1 was omitted from the
cluster analysis because only a single sample showed positive
methylation. The 65 study samples were ordered from left to right
by increasing semen concentration.
Display of Illumina data
llumina data were displayed graphically in Figure 3 with results
for study samples ordered left to right in columns by sperm
concentration. Rows corresponding to each of the 1,421
sequences were divided into three tertiles of median b-value
among buffy coat DNA samples (I, II, III), then sorted within
tertile by median b-value among all sperm DNA samples. Box 1
contains all sequences within tertile I with median b-value
among sperm DNA samples .0.5; box 2 contains all sequences
within tertile III with median b-value among sperm DNA
samples ,0.1. Maternal or paternal imprinting status of each
locus was scored according to the categorization of R. Jirtle [58].
All sequences specific to genes imprinted in humans were
individually reviewed to determine whether they have been
reported as belonging to a DMR for which parent of origin
marks are maintained by DNA methylation [59–81]. Sequences
meeting these criteria were scored as maternally imprinted (MI)
or paternally imprinted (PI) with an indicator set for each on
Figure 3.
SUPPORTING INFORMATION
Table S1 Primers, probes and reaction IDs for 294 MethyLight
Assays; C. Group A: used in screening procedure and analysis of
65 study samples. Group B: used only in screening procedure.
Group C: new assays designed to DMRs of maternally imprinted
genes and used only in analysis of 65 study samples.
Found at: doi:10.1371/journal.pone.0001289.s001 (0.10 MB
PDF)
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Illumina analysis of 1,421 autosomal sequences. This panel is a
subset of the GoldenGate Methylation Cancer Panel I described at www.
illumina.com.Tertiles and heat map of methylation level of CpG
loci are as shown in Figure 3. b-values of all loci for all samples are
given. b-values of the heat map are as follows: Green, b,0.1;
yellow, 0.1#b#0.25; orange, 0.25,b#0.5; red, b.0.5. A to G
represent 7 sperm samples selected from 65 study samples and are
ordered from left to right from lowest to highest sperm
concentration. S, Pre Screen sample; 1 and 2: Buffy Coat samples
1 and 2, respectively; Human maternal or paternal imprinted loci
are indicated with a filled box: IMP, Imprinted; MI, Maternally
Imprinted; PI, Paternally Imprinted.
Found at: doi:10.1371/journal.pone.0001289.s002 (0.20 MB
PDF)
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